Wang, L.; Zhang, L.; Li, S.; Cao, L.; Li, K.; Zhao, W.
A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma. Pharmaceuticals 2023, 16, 1037.
https://doi.org/10.3390/ph16071037
AMA Style
Wang L, Zhang L, Li S, Cao L, Li K, Zhao W.
A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma. Pharmaceuticals. 2023; 16(7):1037.
https://doi.org/10.3390/ph16071037
Chicago/Turabian Style
Wang, Liuying, Liuchao Zhang, Shuang Li, Lei Cao, Kang Li, and Weiwei Zhao.
2023. "A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma" Pharmaceuticals 16, no. 7: 1037.
https://doi.org/10.3390/ph16071037
APA Style
Wang, L., Zhang, L., Li, S., Cao, L., Li, K., & Zhao, W.
(2023). A Novel Acetylation-Immune Subtyping for the Identification of a BET Inhibitor-Sensitive Subgroup in Melanoma. Pharmaceuticals, 16(7), 1037.
https://doi.org/10.3390/ph16071037